Workshop on Developing Position Statements and Guidance For Lipid Management

Thursday 10 August, 1430-1700hrs

A joint initiative of the Australian Atherosclerosis Society Clinical Council, and the Clinical and Prevention Council of the Cardiac Society of Australia and New Zealand.

1430-1700 Workshop on Developing Position Statements and Guidance For Lipid Management Meeting Room 9
 1430-1440 Introduction Gerald F Watts 
Derek Chew
1440-1510  Chair:  Stephen Nicholls  
1440-1450 Use of PCSK9 inhibitors Stephen Nicholls
1450-1500 Assessment and Management of Lp(a) Karam Kostner
1500-1510 Assessing the lipid profile David Sullivan
1510-1550 Chair:  Gerald Watts  
1510-1520 Model of care for FH Gerald Watts 
1520-1530 Genetic testing in lipid disorders Amanda Hooper
1530-1540 Assessing and management of HyperTG Len Kritharides 
1540-1550 Absolute risk assessment and imaging Warrick Bishop
1550-1620 Chair:  Trevor Mori  
1550-1600 Diabetic dyslipidaemia Anthony Keech
1600-1610 Statin intolerance David Sullivan
1610-1620 Nutritional care of the dyslipidaemic patient Paul Nestel 
1620-1700 Chair: David Colquhoun  
1620-1630 Special populations David Hare
1630-1640 Rare dyslipidaemias John Burnett
1640-1650 Complementary therapy in lipid management David Colquhoun
1650-1700 Obesity management in dyslipidaemic patients Paul Nestel 

 

Join our mailing list

Would you like to receive email updates about this Meeting?

© 2017 CSANZ | Meeting is managed by
The Conference Company

Designed & Developed by
72DPI